Skip to main content

NeuroStructure DHA

Boost

400 mg DHA

Sustain

200 mg DHA

Form

AvailOm® High DHA

Bioavailability

5-9× vs Ethyl Esters
The molecule that builds your brain — the single most abundant omega-3 fatty acid in the central nervous system, comprising 50% of neuronal membrane weight. Docosahexaenoic acid (DHA, 22:6n-3) isn’t merely beneficial for brain function — it’s structural. Your neurons are literally built from DHA. This 22-carbon polyunsaturated fatty acid with six double bonds creates the extraordinary membrane fluidity required for synaptic vesicle fusion, receptor conformation changes, and ion channel gating. More remarkably, DHA uniquely drives phosphatidylserine (PS) synthesis in neurons, expanding the PS pool that anchors the Akt survival pathway. When DHA is depleted, PS falls, Akt signaling collapses, and neurons become vulnerable. DHA is also the precursor to Neuroprotectin D1 (NPD1) and other specialized pro-resolving mediators that actively terminate neuroinflammation. NTRPX uses AvailOm® High DHA — a revolutionary lysine-complexed free fatty acid form with 5-9× higher bioavailability than standard fish oil — delivering the brain’s essential building block in its most absorbable state. In ASG Boost and Sustain, NeuroStructure DHA provides the molecular foundation of cognitive architecture.
DHA (all-cis-docosa-4,7,10,13,16,19-hexaenoic acid) operates through four distinct but interconnected mechanisms:

Mechanism 1: Neuronal Membrane Architecture (Primary Mechanism)

DHA’s fundamental role is as the primary structural lipid of neuronal membranes:
Brain RegionDHA ContentFunctional Significance
Gray matter35-40% of phospholipidsNeuronal cell bodies, synapses
Synaptic membranes60-65% of PS molecular speciesSignal transmission
Retina (photoreceptors)60% of PUFAsPhototransduction
HippocampusHigh concentrationLearning and memory
Why Six Double Bonds Matter: DHA’s unique structure — 22 carbons with 6 cis double bonds — creates extraordinary conformational flexibility. The molecule rapidly isomerizes between thousands of conformational states, creating “loosely packed” membrane domains that allow embedded proteins to move, change shape, and function. Without adequate DHA, membrane viscosity increases, receptor function declines, and synaptic transmission becomes sluggish.

Mechanism 2: Phosphatidylserine Synthesis (Critical for Neuronal Survival)

DHA uniquely drives PS accumulation in neurons — a mechanism with profound implications for cell survival:
PS Synthesis StepDHA’s RoleEvidence
PSS1 substrate18:0,22:6-PC is best substrateKim et al. 2004
PSS2 substrate18:0,22:6-PE is best substrateWen & Kim 2007
PS accumulationDHA uniquely increases neuronal PSGarcia et al. 1998
Neuron-specificEffect occurs only in neuronsGuo et al. 2007
Key Finding (Kim Laboratory, NIH): DHA-containing phospholipids (PC and PE) are the preferred substrates for phosphatidylserine synthase enzymes. When neurons are supplemented with DHA, PS content increases specifically in neuronal cells — not in other cell types like CHO-K1 or HEK-293. This neuron-specific PS expansion has profound consequences:
  1. PS provides the docking site for Akt’s PH domain
  2. Akt membrane translocation is required for phosphorylation and activation
  3. Activated Akt phosphorylates pro-survival targets (Bad, GSK-3β, FOXO)
  4. Result: Enhanced neuronal survival under stress conditions
n-3 Fatty Acid Deficiency: When dietary DHA is depleted, brain PS falls by 25-35% specifically in neuronal tissues (cortex, hippocampus, olfactory bulb, retina). Liver and adrenal PS remain unchanged — demonstrating the neuron-specific nature of DHA-PS coupling.

Mechanism 3: Specialized Pro-Resolving Mediators (SPMs)

DHA is the precursor to D-series resolvins, protectins, and maresins — bioactive lipid mediators that actively resolve inflammation:
SPMPrecursorKey ActionsPotency
Neuroprotectin D1 (NPD1)DHA via 15-LOXNeuroprotection, anti-Aβ, anti-apoptoticPicomolar
Resolvin D1 (RvD1)DHA via 15-LOX/5-LOXStops neutrophil transmigrationNanomolar
Resolvin D2 (RvD2)DHA via 15-LOX/5-LOXReduces inflammatory cytokinesNanomolar
Maresin 1 (MaR1)DHA via 12-LOXPromotes macrophage efferocytosisNanomolar
Neuroprotectin D1 — The Brain’s Resolution Signal:
  • Synthesized in brain tissue from DHA in response to oxidative stress
  • Potent protection against amyloid-β-induced apoptosis
  • Inhibits COX-2 expression and pro-inflammatory gene transcription
  • Promotes pro-survival Bcl-2 family protein expression
  • Active at picomolar concentrations — extraordinarily potent

Mechanism 4: BDNF Upregulation and Neuroplasticity

DHA enhances brain-derived neurotrophic factor (BDNF) through epigenetic and transcriptional mechanisms:
BDNF EffectDHA ContributionCognitive Relevance
↑ BDNF mRNACREB activationLearning capacity
↑ Synaptic proteinsSynapsin-1, PSD-95, GluR-1Memory consolidation
↑ Dendritic spines30%+ increase in hippocampusNeural connectivity
Enhanced LTPStronger synaptic potentiationMemory formation

Molecular Identity

PropertyValue
IUPAC Name(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid
Notation22:6(n-3) or 22:6ω3
SynonymsCervonic acid, DHA
Molecular FormulaC₂₂H₃₂O₂
Molecular Weight328.49 g/mol
CAS Number6217-54-5
Double Bonds6 (all cis configuration)
Melting Point-44°C (liquid at body temperature)

The Bioavailability Problem

Traditional omega-3 supplements face fundamental absorption challenges:

AvailOm® High DHA Specifications

ParameterSpecification
FormOmega-3 lysine complex powder
DHA Content≥30% free fatty acid by weight
EPA Content~15% free fatty acid by weight
Total EPA+DHA≥50% as free fatty acids
Lysine Content~14% L-lysine (essential amino acid)
AppearanceFree-flowing powder
Stability>4 years at 25°C (no refrigeration)
RegulatoryGRAS (FDA), NDI registered, Novel Food (EU)

Clinical Bioavailability Evidence

Wageningen University Study (2020):
  • First in-human pharmacokinetic trial
  • Crossover design: AvailOm® vs standard ethyl ester
  • Result: 5× higher AUC for AvailOm®
  • Faster Tmax (peak reached earlier)
BioTeSys Three-Way Crossover RCT (2024):
  • 21 healthy subjects (10 men, 11 women)
  • Three-way crossover: AvailOm® vs EE vs TG
  • Results:
Comparison0-12h Bioavailability0-24h Bioavailability
AvailOm® vs Ethyl Ester9.33× higher8.09× higher
AvailOm® vs Triglyceride1.57× higher1.44× higher

Why Lysine Complexation Works

  1. Stabilization: Lysine (cationic amino acid) forms ionic complex with free fatty acid (anionic)
  2. Powder form: Creates stable, dry powder from liquid oil
  3. Gastric dissociation: Complex rapidly breaks down at gastric pH
  4. Direct absorption: Free fatty acids absorbed directly by enterocytes
  5. No enzymatic step: Bypasses need for pancreatic lipase
  6. No bile dependence: Absorbs efficiently regardless of dietary fat

Bonus: L-Lysine

AvailOm® provides ~14% L-lysine by weight — an essential amino acid:
  • Required for carnitine synthesis (fat transport into mitochondria)
  • Supports collagen formation
  • Enhances calcium absorption
  • Contributes to daily amino acid requirements

DHA and Cognitive Function

StudyPopulationDose/DurationKey Findings
Lee et al. (2013)MCI, 12 months1491mg DHA + 351mg EPA↑ Short-term memory, working memory, immediate verbal memory, delayed recall
Stonehouse et al. (2013)Healthy young adults1160mg DHA, 6 months↑ Episodic memory (women), ↓ RT working memory (men)
Zhang et al. (2018)MCI, 12 months2g DHA/day↑ Full-scale IQ, Information, Digit Span; slowed hippocampal atrophy
Yurko-Mauro et al. (2010)ARCD, 24 weeks900mg DHA/day↑ Paired associate learning (PAL) memory

DHA and Brain Volume/Structure

Zhang et al. 2016 (Tianjin, China):
  • 240 MCI subjects, 12-month RCT
  • 2g DHA/day vs corn oil placebo
  • Results:
OutcomeDHA EffectP-value
Left hippocampal volumePreservedp = 0.016
Right hippocampal volumePreservedp = 0.008
Total hippocampal volumePreservedp = 0.023
Global cerebrum volumePreservedp = 0.032
Full-Scale IQImprovedp = 0.039
Digit SpanImprovedp < 0.001
Interpretation: DHA supplementation at 2g/day for 12 months significantly slowed hippocampal atrophy and improved cognitive function in MCI patients.

DHA Brain Delivery (CSF Penetration)

Arellanes et al. (2020) — eBioMedicine:
  • 33 cognitively unimpaired adults
  • 2,152mg DHA/day for 6 months
  • Lumbar puncture before and after
OutcomeChangeP-value
CSF DHA+28%p < 0.0001
CSF EPA+43%p < 0.0001
APOE4 Effect: Non-APOE4 carriers had 3× greater CSF EPA increase than APOE4 carriers, suggesting APOE4 carriers may need higher doses.

Meta-Analysis: Dose-Response Relationship

2025 Meta-Analysis (Scientific Reports):
  • 58 RCTs included
  • Dose-response analysis per 2000mg/day omega-3
Cognitive DomainSMD per 2g/day95% CIGRADE
Attention0.980.41–1.54Low
Perceptual speed0.500.05–0.95Moderate
Language0.370.12–0.62Moderate
Conclusion: Higher omega-3 doses (≥2g/day) show dose-dependent cognitive benefits.

Stage-Dependent Effects

Clinical evidence consistently shows DHA is most effective when initiated before significant cognitive decline:
PopulationDHA EfficacyInterpretation
Healthy adultsPositive (memory, RT)Prevention potential
Mild cognitive impairmentPositive (multiple domains)Early intervention effective
Early Alzheimer’s (MMSE >27)PositiveNarrow therapeutic window
Moderate-severe Alzheimer’sNegativeToo late; damage irreversible

APOE Genotype Considerations

APOE4 carriers show altered DHA metabolism:
  • Less efficient DHA delivery to brain
  • Lower CSF DHA increase after supplementation
  • May require higher doses for equivalent brain effects
  • Shorter DHA half-life in plasma
Clinical Implication: APOE4 carriers may benefit from higher DHA doses or longer supplementation periods.

DHA + Phosphatidylserine (Synergistic PS Expansion)

DHA and exogenous PS work through complementary mechanisms:NTRPX Synergy: ASG Boost contains both DHA (400mg) and Phosphatidylserine (100mg), providing dual-pathway PS optimization.

DHA + Choline + Uridine (Kennedy Cycle)

The “Kennedy Cycle” for phosphatidylcholine synthesis is enhanced by DHA:MIT Research (Wurtman Lab): Combined DHA + choline + uridine supplementation increases hippocampal synapses by 30%+ in animal models.NTRPX Implementation:
  • DHA from AvailOm® High DHA
  • Choline from CDP-Choline (Citicoline)
  • Uridine provided by CDP-Choline breakdown

DHA + Vitamin D3 + K2 (Fat-Soluble Triad)

Synergy Logic:
  • DHA provides optimal membrane environment for vitamin D receptor function
  • Vitamin D regulates serotonin synthesis — DHA enhances serotonin receptor function
  • K2 activates Gas6 (neuroprotective) — requires proper membrane integration
  • AvailOm® oil matrix enhances absorption of fat-soluble vitamins

DHA + EPA (Complementary Omega-3s)

Omega-3Primary RoleBrain FateNTRPX Timing
DHAStructural (membrane)Incorporated into phospholipidsAM (Boost)
EPASignaling (anti-inflammatory)Rapidly metabolized to SPMsPM (Recover)
NTRPX Strategy: DHA-predominant in morning products (structural foundation), EPA-predominant in evening products (inflammation resolution during sleep).

DHA + Magnesium

Magnesium RoleDHA Interaction
Enzyme cofactorRequired for fatty acid metabolism enzymes
Membrane stabilityBoth modulate membrane fluidity
GABA functionBoth support GABAergic signaling
Anti-inflammatoryComplementary pathways

NTRPX DHA Distribution

ProductDHA DoseEPA DoseTotal ω-3Timing Rationale
ASG Boost™400mg300mg700mgMorning structural foundation
ASG Sustain™200mg100mg300mgAfternoon maintenance
ASG Recover™100mg300mg400mgEvening EPA-dominant recovery
Daily Total700mg700mg1,400mgComprehensive coverage

Effective Dose Equivalency

AvailOm® bioavailability advantage means lower doses achieve equivalent plasma levels:
AvailOm® DoseEquivalent Ethyl Ester DoseEquivalent TG Dose
100mg DHA500-900mg DHA (EE)140-160mg DHA (TG)
400mg DHA2,000-3,600mg DHA (EE)560-640mg DHA (TG)
700mg DHA (daily)3,500-6,300mg DHA (EE)980-1,120mg DHA (TG)
Implication: NTRPX’s 700mg DHA from AvailOm® delivers the equivalent brain exposure of 3,500-6,300mg from standard fish oil softgels.

Evidence-Based Dosing by Indication

IndicationDHA DoseDurationEvidence Level
General brain health250-500mgOngoingStrong
Cognitive optimization500-1,000mgOngoingModerate-Strong
MCI intervention1,000-2,000mg12+ monthsStrong
Pregnancy/lactation200-600mgGestation + nursingStrong (critical)
Cardiovascular500-1,000mgOngoingStrong

Timing Considerations

TimingRationaleNTRPX Implementation
With foodEnhanced absorption (though AvailOm® less food-dependent)Recommended with meals
Morning emphasisDHA structural role; cognitive primingBoost (400mg DHA)
Split dosingMaintains more stable plasma levelsBoost + Sustain
Evening EPAResolution during sleep/recoveryRecover (EPA-dominant)

Population-Specific Dosing

PopulationDHA ConsiderationNTRPX Guidance
Healthy adults500-700mg/day adequateStandard protocol
APOE4 carriersMay need higher dosesConsider adding fatty fish 2×/week
Elderly (65+)Higher baseline needStandard protocol appropriate
PregnancyCritical for fetal brainConsult physician; DHA essential
Vegetarian/veganAlgal DHA optionAvailOm® is fish-derived; algal alternatives exist

Omega-3 Content of Common Foods

Food SourceServingDHA (mg)EPA (mg)Total ω-3 (mg)
Atlantic Salmon (wild)3 oz (85g)1,2405901,830
Atlantic Salmon (farmed)3 oz (85g)1,0905901,680
Atlantic Mackerel3 oz (85g)1,4005004,580*
Sardines (canned)3 oz (85g)7404501,190
Herring3 oz (85g)9407701,710
Anchovies3 oz (85g)8707601,630
Rainbow Trout (farmed)3 oz (85g)500400900
Albacore Tuna3 oz (85g)530200730
Oysters (raw)6 medium200260460
Cod3 oz (85g)13050180
*Mackerel includes additional omega-3s beyond EPA+DHA

Food Equivalents for NTRPX Daily DHA

To match NTRPX’s 700mg DHA from AvailOm® (accounting for 5-9× bioavailability = 3,500-6,300mg equivalent):
Food SourceAmount Needed DailyPractical?Notes
Wild Salmon10-18 oz (280-510g)✗ ImpracticalCost: $15-30/day
Canned Sardines15-27 oz (425-765g)✗ Impractical4-7 cans/day
Mackerel7-13 oz (200-370g)⚠️ ChallengingMercury consideration
Herring12-21 oz (340-595g)✗ ImpracticalRare in Western diet
Reality Check: Achieving equivalent DHA brain exposure through food alone is extremely difficult due to:
  1. Standard fish oil absorption is 5-9× lower than AvailOm®
  2. Cost of high-quality fatty fish
  3. Practical consumption limits
  4. Mercury exposure with large fish
  5. Preparation time

Dietary Strategy for NTRPX Users

Optimized Approach: Use NTRPX omega-3s as reliable baseline; add whole food sources for additional benefits:
Weekly TargetRationaleFoods
2-3 fatty fish servingsProvides matrix of nutrients beyond DHASalmon, sardines, mackerel
Seafood varietyAdditional minerals (zinc, selenium, iodine)Oysters, mussels, shrimp
Low-mercury choicesSafetySardines, anchovies, herring

Why Not Plant Sources?

SourceOmega-3 TypeConversion to DHAPractical DHA
FlaxseedALA<0.5% conversionNegligible
Chia seedsALA<0.5% conversionNegligible
WalnutsALA<0.5% conversionNegligible
Hemp seedsALA<0.5% conversionNegligible
Conversion Problem: Humans convert ALA → EPA → DHA extremely inefficiently:
  • ALA → EPA: ~5-10%
  • ALA → DHA: <0.5%
Plant sources cannot meaningfully contribute to DHA status. Direct DHA from marine sources (fish, algae) is required.

Cost Comparison

SourceDaily Cost for Equivalent DHA
Wild salmon (6+ oz/day)$15-25
Quality fish oil softgels (8-12 caps)$2-4
NTRPX (AvailOm® DHA)Included in system
AvailOm® (standalone)~$1-2
Value Proposition: AvailOm® provides superior bioavailability at a fraction of whole food cost, without mercury concerns or preparation requirements.

Adverse Event Profile

EventIncidenceSeverityNotes
Fishy aftertasteRare with AvailOm®MinimalLysine complex prevents
GI upsetUncommonMildLess than ethyl esters
Loose stoolsRareMildHigh doses only
Prolonged bleeding timeTheoreticalN/AOnly at very high doses
At NTRPX doses (700mg DHA/day), adverse events are uncommon and mild.

Safety Data

ParameterFindingSource
Human clinical (up to 3g/day)No serious adverse eventsMultiple RCTs
FDA GRASUp to 3g/day EPA+DHAFDA
EFSAUp to 5g/day EPA+DHAEFSA 2012
Oxidation markersNo increase at clinical dosesMultiple studies
LDL cholesterolModest increase possible at high dosesMonitor if concerned
AvailOm® stability>4 years, low oxidationEvonik data

Regulatory Status

RegionStatusNotes
United StatesGRAS; dietary supplementNDI registered
European UnionNovel Food approvedAvailOm® specifically
JapanFood ingredientLong history
CanadaNHP eligibleLicensed products

Drug Interactions

Drug ClassInteractionSeverityRecommendation
Anticoagulants (warfarin)Additive bleeding risk★★★☆☆Monitor INR
Antiplatelet (aspirin, clopidogrel)Additive effect★★☆☆☆Generally safe; monitor
AntihypertensivesAdditive BP lowering★☆☆☆☆May allow dose reduction
StatinsComplementary★☆☆☆☆Beneficial combination

Contraindications

CategoryConsiderationSeverity
Fish/shellfish allergyUse algal DHA alternative★★★★★ Absolute
Scheduled surgeryStop 1-2 weeks before★★★☆☆ Temporary
Active bleedingAvoid until resolved★★★★☆ Temporary

Special Populations

PopulationSafety StatusNotes
Healthy adultsExcellentWell-tolerated
PregnancyEssentialDHA critical for fetal brain; 200-600mg recommended
LactationEssentialDHA transfers to breast milk
ChildrenExcellentAge-appropriate dosing
ElderlyExcellentMay have higher requirements
APOE4 carriersSafeMay need higher doses for effect

Tier 1: Foundation

Efficacy

High — Essential structural nutrient

Validation

Strong — Extensive RCTs, mechanism elucidated

Safety

Excellent — GRAS, essential nutrient, long history
Tier Rationale: Tier 1 (Foundation) classification. DHA is not optional — it’s essential for brain structure, comprising 50% of neuronal membrane weight. Unlike most supplements that modulate function, DHA is literally structural. The brain cannot be built or maintained without it. Depletion causes measurable deficits in PS content, Akt signaling, and cognitive function. Human clinical trials demonstrate benefits for memory, hippocampal volume preservation, and cognitive function across multiple populations. The mechanism is definitively established: membrane architecture, PS synthesis, SPM production, and BDNF modulation. AvailOm® technology provides 5-9× superior bioavailability over standard supplements, ensuring actual brain delivery. Safety is excellent — DHA is an essential nutrient with GRAS status and extensive human data, including in pregnancy where it’s actively recommended.

When to Use DHA

ScenarioExpected BenefitProtocol
Cognitive optimizationHigh400-700mg daily, ongoing
Memory supportHigh500-1000mg daily, 6+ months
MCI interventionHigh1000-2000mg daily, 12+ months
Pregnancy/nursingCritical200-600mg daily, entire period
CardiovascularHigh500-1000mg daily, ongoing
General wellnessModerate-High250-500mg daily, ongoing

Realistic Expectations

TimeframeWhat to Expect
Week 1-2Plasma DHA rising; minimal subjective effects
Week 4-8RBC membrane composition changing
Month 3Brain DHA increasing; subtle cognitive effects
Month 6+Measurable cognitive and structural benefits
OngoingMaintained brain architecture; prevention effects
Key Insight: DHA is a structural intervention. Unlike acute-acting compounds, DHA slowly incorporates into membrane phospholipids. Full effects require months of consistent supplementation.

Signs It’s Working

IndicatorDescription
↑ Mental clarityImproved focus and processing
↑ MemoryBetter recall, especially episodic
↓ Brain fogReduced cognitive fatigue
Mood stabilityMore even emotional state
Visual functionPotentially improved (DHA in retina)

Optimizing Response

StrategyRationale
Take with mealsEnhanced absorption (less critical with AvailOm®)
Consistent daily useMembrane incorporation requires chronic dosing
Combine with PSDual-pathway PS optimization
Include cholineKennedy Cycle synergy
Ensure vitamin DReceptor function requires membrane fluidity
Add fatty fishWhole food matrix benefits

Frequently Asked Questions

DHA is the active molecule — one of the omega-3 fatty acids in fish oil. Standard fish oil contains a mix of omega-3s (typically 30% EPA+DHA), plus other fatty acids. NTRPX uses concentrated DHA in the highly bioavailable AvailOm® form, ensuring you get the specific brain-building fatty acid in optimal amounts without filler fats.
DHA is a structural molecule — it physically incorporates into your neuronal membranes. This isn’t like caffeine (instant effect) or even adaptogens (weeks). Membrane remodeling takes time: DHA must be absorbed, transported to the brain, acylated into phospholipids, and distributed across billions of neurons. Full membrane saturation requires 3-6 months of consistent supplementation.
Theoretically yes, but practically difficult. You’d need to eat fatty fish (salmon, mackerel, sardines) almost daily. Most people eat fish 1-2× per week at best, providing ~100mg DHA daily — far below optimal. Factor in cost ($15-25/day for adequate salmon), mercury concerns, and convenience, and supplementation becomes the practical solution.
Plant sources provide ALA (alpha-linolenic acid), not DHA. Humans convert ALA to DHA at <0.5% efficiency. You cannot meaningfully raise brain DHA levels with flax or chia seeds. If avoiding fish, use algae-derived DHA supplements (the original DHA source that fish accumulate).
Absolutely. Standard ethyl ester fish oil has 5-9× lower bioavailability than AvailOm®. You’d need to take 5-9 standard capsules to match one AvailOm® dose. Factor in the superior stability (no refrigeration, 4+ year shelf life), absence of fishy burps, and predictable absorption regardless of meal fat content — AvailOm® is the superior technology.
Possibly. Research shows APOE4 carriers have less efficient DHA brain delivery and lower CSF DHA increases after supplementation. While the standard NTRPX dose provides excellent coverage, APOE4 carriers may benefit from additional fatty fish consumption or considering the upper end of dosing ranges. Discuss with a physician if you know your APOE status.
DHA is essential during pregnancy — it’s critical for fetal brain and eye development. International guidelines recommend 200-600mg DHA daily during pregnancy and lactation. However, pregnant women should consult their physician before taking any supplements, including NTRPX products.
The omega-3 with strongest antidepressant evidence is EPA, not DHA. DHA supports brain structure and serotonin receptor function, but EPA more directly modulates inflammatory pathways linked to depression. NTRPX provides both: DHA-predominant in Boost/Sustain for structure, EPA-predominant in Recover for mood/inflammation.

NeuroStructure Summary: DHA (Docosahexaenoic Acid) at 700mg daily via AvailOm® High DHA is the structural foundation of cognitive architecture — comprising 50% of neuronal membrane weight and uniquely driving phosphatidylserine synthesis for Akt survival signaling. With 5-9× superior bioavailability over standard fish oil, AvailOm® ensures actual brain delivery of this essential fatty acid. Human clinical trials demonstrate preservation of hippocampal volume, improved memory, and cognitive benefits across multiple populations. DHA also serves as the precursor to Neuroprotectin D1 and other specialized pro-resolving mediators that terminate neuroinflammation. In NTRPX ASG Boost and Sustain, NeuroStructure DHA delivers the molecular foundation your neurons are literally built from.

Version: 1.0 | Last Updated: January 23, 2026 | Document Status: Complete Clinical MonographThis monograph establishes the DHA framework for NTRPX Systems. AvailOm® High DHA has been selected as the gold-standard delivery form based on superior bioavailability (5-9× vs ethyl esters), stability (>4 years), and clinical validation. Doses and product placements are optimized for synergy with phosphatidylserine, choline, and other NTRPX ingredients.